
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.6B | $3.8B | $4.7B | $2B | $1.7B | |
Revenue Growth (YoY) | 0.9% | 50.49% | 21.88% | -57.33% | -17.23% | |
Cost of Revenues | $1.5B | $2B | $2.4B | $1.1B | $843.7M | |
Gross Profit | $1B | $1.8B | $2.3B | $902.8M | $809M | |
Gross Profit Margin | 41.14% | 47.64% | 48.2% | 45.21% | 48.95% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $367.2M | $443M | $516.9M | $254.1M | $254.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $951.1M | $1.2B | $1.2B | $626.2M | $648.5M | |
Operating Income | $98.3M | $669.7M | $1.1B | $276.5M | $160.5M | |
Net Interest Expenses | $26.1M | $27.4M | $25.7M | $50M | $63.9M | |
EBT. Incl. Unusual Items | $62M | $676.2M | $1.3B | $272M | $141.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -$182.1M | -$142.7M | |
Income Tax Expense | $32.5M | $135M | $269.6M | $73.8M | -$54.6M | |
Net Income to Company | $87.8M | $671.3M | $1.3B | $158.9M | $66.1M | |
Minority Interest in Earnings | -$4.1M | -$4.2M | -$8.3M | -$9.3M | -$8.3M | |
Net Income to Common Excl Extra Items | $25.4M | $537M | $993.7M | $6.8M | $45.3M | |
Basic EPS (Cont. Ops) | $0.04 | $0.87 | $1.57 | $0.01 | $0.07 | |
Diluted EPS (Cont. Ops) | $0.04 | $0.86 | $1.56 | $0.01 | $0.07 | |
Weighted Average Basic Share | $581.3M | $618.2M | $633.6M | $635M | $634M | |
Weighted Average Diluted Share | $581.4M | $622M | $635.6M | $635.8M | $634.1M | |
EBITDA | $274.3M | $926.6M | $1.5B | $562.1M | $478.3M | |
EBIT | $91M | $707M | $1.3B | $334.8M | $213.6M | |
Revenue (Reported) | $2.6B | $3.8B | $4.7B | $2B | $1.7B | |
Operating Income (Reported) | $98.3M | $669.7M | $1.1B | $276.5M | $160.5M | |
Operating Income (Adjusted) | $91M | $707M | $1.3B | $334.8M | $213.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Revenue | $854.2M | $1.3B | $832.9M | $442.8M | $416.9M | |
Revenue Growth (YoY) | 50.53% | 49.92% | -34.96% | -46.83% | -5.87% | |
Cost of Revenues | $428.5M | $589.1M | $467.8M | $207.3M | $199.2M | |
Gross Profit | $425.7M | $691.5M | $365.1M | $235.6M | $217.6M | |
Gross Profit Margin | 49.84% | 54% | 43.84% | 53.19% | 52.21% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $319.1M | $345.6M | $326.7M | $166M | $194.4M | |
Operating Income | $106.7M | $345.9M | $38.4M | $69.6M | $23.3M | |
Net Interest Expenses | $7.6M | $6.5M | $12M | $15.9M | $13.2M | |
EBT. Incl. Unusual Items | $94M | $399.1M | $23.8M | $40.4M | -$12.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -$43.1M | -$19.7M | |
Income Tax Expense | $20.4M | $83.6M | $18M | -$84.2M | -$4.5M | |
Net Income to Company | $104M | $374.7M | $35.7M | $19.4M | $18.7M | |
Minority Interest in Earnings | -$1.1M | -$2.1M | -$2.3M | -$2.5M | -$2.2M | |
Net Income to Common Excl Extra Items | $72.6M | $313.3M | $3.4M | $79.1M | -$29.8M | |
Basic EPS (Cont. Ops) | $0.12 | $0.49 | $0.01 | $0.13 | -$0.05 | |
Diluted EPS (Cont. Ops) | $0.12 | $0.49 | $0.01 | $0.13 | -$0.05 | |
Weighted Average Basic Share | $623.5M | $633.7M | $635.8M | $634M | $634.2M | |
Weighted Average Diluted Share | $627.2M | $637.4M | $636.8M | $634M | $634.3M | |
EBITDA | $166M | $459.5M | $92.9M | $129M | $62.7M | |
EBIT | $102.7M | $407.1M | $39.8M | $58.2M | $1.7M | |
Revenue (Reported) | $854.2M | $1.3B | $832.9M | $442.8M | $416.9M | |
Operating Income (Reported) | $106.7M | $345.9M | $38.4M | $69.6M | $23.3M | |
Operating Income (Adjusted) | $102.7M | $407.1M | $39.8M | $58.2M | $1.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Revenue | $3.1B | $4.7B | $3.9B | $2.1B | $1.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.7B | $2.4B | $2.2B | $1.1B | $911.5M | |
Gross Profit | $1.3B | $2.4B | $1.7B | $953.4M | $994.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.1B | $1.2B | $1.2B | $818.8M | $841M | |
Operating Income | $259.2M | $1.2B | $488.3M | $134.7M | $153.3M | |
Net Interest Expenses | $29.2M | $24.4M | $35.8M | $73.9M | $59.1M | |
EBT. Incl. Unusual Items | $213.2M | $1.3B | $661.5M | $31.1M | $67M | |
Earnings of Discontinued Ops. | -- | -- | -- | -$127.6M | -$73.9M | |
Income Tax Expense | $56.7M | $264M | $163.7M | -$56.8M | $27.3M | |
Net Income to Company | $235.8M | $1.2B | $718.9M | -$17.7M | $89.8M | |
Minority Interest in Earnings | -$3.8M | -$5.5M | -$10.1M | -$8.9M | -$7.6M | |
Net Income to Common Excl Extra Items | $152.9M | $993.1M | $487.5M | -$48.5M | -$42M | |
Basic EPS (Cont. Ops) | $0.25 | $1.57 | $0.77 | -$0.08 | -$0.07 | |
Diluted EPS (Cont. Ops) | $0.25 | $1.56 | $0.77 | -$0.08 | -$0.07 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $456.2M | $1.5B | $917.2M | $365.4M | $395.4M | |
EBIT | $244M | $1.3B | $709M | $115.8M | $133.9M | |
Revenue (Reported) | $3.1B | $4.7B | $3.9B | $2.1B | $1.9B | |
Operating Income (Reported) | $259.2M | $1.2B | $488.3M | $134.7M | $153.3M | |
Operating Income (Adjusted) | $244M | $1.3B | $709M | $115.8M | $133.9M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $2.6B | $1.8B | $877M | $797.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $838.8M | $1.2B | $980.5M | $428.1M | $373.1M | |
Gross Profit | $838.5M | $1.4B | $794M | $448.8M | $424.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $637.8M | $675.4M | $663.4M | $326.5M | $365.8M | |
Operating Income | $200.8M | $713.8M | $130.6M | $122.3M | $58.5M | |
Net Interest Expenses | $15.2M | $11.6M | $21.9M | $32.9M | $26.2M | |
EBT. Incl. Unusual Items | $190.5M | $782.3M | $158.8M | $55.9M | $12.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -$88.3M | -$51M | |
Income Tax Expense | $35.9M | $166M | $57.3M | -$74.7M | $5.9M | |
Net Income to Company | $190.9M | $755.1M | $183.8M | $7.1M | $30.8M | |
Minority Interest in Earnings | -$2M | -$3.4M | -$5.3M | -$4.9M | -$4.2M | |
Net Income to Common Excl Extra Items | $152.6M | $612.8M | $96.2M | $37.5M | -$49M | |
Basic EPS (Cont. Ops) | $0.25 | $0.97 | $0.15 | $0.06 | -$0.08 | |
Diluted EPS (Cont. Ops) | $0.25 | $0.96 | $0.15 | $0.06 | -$0.08 | |
Weighted Average Basic Share | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | |
Weighted Average Diluted Share | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | |
EBITDA | $319.7M | $902.9M | $294.8M | $220.9M | $166.2M | |
EBIT | $206.7M | $796.8M | $189M | $92.5M | $40.6M | |
Revenue (Reported) | $1.7B | $2.6B | $1.8B | $877M | $797.4M | |
Operating Income (Reported) | $200.8M | $713.8M | $130.6M | $122.3M | $58.5M | |
Operating Income (Adjusted) | $206.7M | $796.8M | $189M | $92.5M | $40.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $369.5M | $798.1M | $944.3M | $626M | $387.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $219.6M | $374.9M | $322.6M | $234.7M | $149.1M | |
Inventory | $613.9M | $874.7M | $1.1B | $886.7M | $532.6M | |
Prepaid Expenses | $19.2M | $31.1M | $26M | $24.4M | $9.2M | |
Other Current Assets | $702.8K | $3.4M | $1.3M | $1.7M | $1.9M | |
Total Current Assets | $1.5B | $2.4B | $2.7B | $2.1B | $3.6B | |
Property Plant And Equipment | $1.8B | $1.9B | $2.1B | $2.3B | $778.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $107.7M | $106.7M | $100.4M | $99.8M | $29M | |
Other Intangibles | $154.6M | $181.7M | $141.4M | $143.4M | $19.1M | |
Other Long-Term Assets | $4.1M | $1.8M | $3.9M | $4.5M | $67.7M | |
Total Assets | $3.6B | $4.7B | $5.4B | $5B | $4.7B | |
Accounts Payable | $369.8M | $523.1M | $544.3M | $519.3M | $183.1M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $11.4M | $13.2M | $10.5M | $12.3M | $5.9M | |
Other Current Liabilities | $52.6M | $73M | $44.1M | $33.4M | $13.8M | |
Total Current Liabilities | $1.1B | $1.4B | $1.2B | $1B | $1.3B | |
Long-Term Debt | $775.8M | $875.6M | $1B | $1.3B | $1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.1B | $2.5B | $2.4B | $2.6B | $2.4B | |
Common Stock | $737.5M | $362.4M | $326.2M | $314.3M | $282M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $1.5B | $2.2B | $2.9B | $2.4B | $2.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $12.7M | $9.7M | $13.7M | $13.1M | $9.6M | |
Total Equity | $1.5B | $2.3B | $2.9B | $2.4B | $2.3B | |
Total Liabilities and Equity | $3.6B | $4.7B | $5.4B | $5B | $4.7B | |
Cash and Short Terms | $369.5M | $798.1M | $944.3M | $626M | $387.8M | |
Total Debt | $1.3B | $1.3B | $1.2B | $1.5B | $1.1B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $700.5M | $814.2M | $611.6M | $488.1M | $287.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $398M | $542.7M | $363.5M | $343.6M | $212.2M | |
Inventory | $645.5M | $904.8M | $962.5M | $741.3M | $576.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $171.7M | $210.5M | $184.1M | $164.1M | $92.3M | |
Total Current Assets | $2B | $2.7B | $2.2B | $1.8B | $3.6B | |
Property Plant And Equipment | $1.7B | $1.9B | $2.1B | $2.2B | $873.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $107.8M | $101.3M | $104.6M | $93.1M | $30.3M | |
Other Intangibles | $172.4M | $143.5M | $136.3M | $114.4M | $18.9M | |
Other Long-Term Assets | $44.6M | $56.9M | $67.1M | $126.1M | $97.8M | |
Total Assets | $4.1B | $5B | $4.9B | $4.5B | $4.8B | |
Accounts Payable | $403.9M | $469.2M | $476.5M | $441.9M | $162M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $12.6M | $10.7M | $10.4M | $10.5M | $6.9M | |
Other Current Liabilities | -- | -- | $118.5M | $99.7M | $81.9M | |
Total Current Liabilities | $1.1B | $1.3B | $1.1B | $899.5M | $1.2B | |
Long-Term Debt | $916.7M | $892.3M | $1.1B | $1.1B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.2B | $2.4B | $2.5B | $2.2B | $2.4B | |
Common Stock | $947.2M | $628.5M | $324.4M | $314M | $347.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $9.7M | $12.5M | $13.7M | $13.7M | $12.6M | |
Total Equity | $1.9B | $2.6B | $2.4B | $2.3B | $2.4B | |
Total Liabilities and Equity | $4.1B | $5B | $4.9B | $4.5B | $4.8B | |
Cash and Short Terms | $700.5M | $814.2M | $611.6M | $488.1M | $287.9M | |
Total Debt | $1.3B | $1.2B | $1.4B | $1.4B | $1.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $87.8M | $671.3M | $1.3B | $158.9M | $66.1M | |
Depreciation & Amoritzation | $183.4M | $219.5M | $207.7M | $227.3M | $264.7M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | $33.7M | $87.3M | $1.2M | |
Change in Inventories | -- | -- | -$234.7M | $156.8M | -$41.5M | |
Cash From Operations | $224.1M | $570.1M | $968M | $261.6M | $188.4M | |
Capital Expenditures | $249.1M | $379M | $437.9M | $471.3M | $315.3M | |
Cash Acquisitions | -$113.8M | -$9.1M | -$44.2M | -$49M | $556.8K | |
Cash From Investing | -$346.3M | -$369.6M | -$457.7M | -$500.7M | -$306.5M | |
Dividends Paid (Ex Special Dividend) | -$37.1M | -$11.1M | -$197.5M | -$360.5M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $173.7M | $368.7M | $691M | $369.5M | $229.2M | |
Long-Term Debt Repaid | -$152.1M | -$369M | -$752.2M | -$24.8M | -$136.8M | |
Repurchase of Common Stock | -- | -$32.3M | -- | -- | -- | |
Other Financing Activities | $12M | $82.3M | -- | -- | $185.6K | |
Cash From Financing | -$17.6M | $238.6M | -$301.3M | -$46M | $68.4M | |
Beginning Cash (CF) | $477.3M | $366M | $731.7M | $874.4M | $590.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$139.8M | $439.1M | $209M | -$285.1M | -$49.7M | |
Ending Cash (CF) | $334.9M | $816.9M | $961.9M | $601.6M | $563.3M | |
Levered Free Cash Flow | -$25M | $191.1M | $530.2M | -$209.7M | -$127M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $104M | $374.7M | $35.7M | $19.4M | $18.7M | |
Depreciation & Amoritzation | $64.1M | $49.2M | $50.5M | $69.5M | $65.8M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $127.1M | $254.4M | $102.8M | $35M | $88.6M | |
Capital Expenditures | $62.2M | $81.8M | $112.3M | $64.3M | $70.1M | |
Cash Acquisitions | -$9.3M | -$20.6M | -$42.1M | -$13K | -- | |
Cash From Investing | -$76.3M | -$100.6M | -$149.8M | -$63.3M | -$68.9M | |
Dividends Paid (Ex Special Dividend) | -$11.4M | -$201M | -$355.5M | -- | -$18.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $53.5M | $525M | -$7.4M | $29.5M | $3.5M | |
Long-Term Debt Repaid | -$97.2M | -$488.4M | -$3.7M | -$19.9M | -$31.9M | |
Repurchase of Common Stock | $875.9K | -- | -- | -- | -- | |
Other Financing Activities | -$236.2K | -$105.8K | -$21.8M | -- | -- | |
Cash From Financing | $161.6M | -$206M | -$382.7M | $3.1M | -$53.5M | |
Beginning Cash (CF) | $489.6M | $915.6M | $1.1B | $554.6M | $399.1M | |
Foreign Exchange Rate Adjustment | $6M | $37.2M | -$516.3K | -$11.5M | -$5.1M | |
Additions / Reductions | $212.4M | -$52.3M | -$429.7M | -$25.1M | -$33.9M | |
Ending Cash (CF) | $714.9M | $852.1M | $615.9M | $504.3M | $401.1M | |
Levered Free Cash Flow | $64.9M | $172.5M | -$9.5M | -$29.3M | $18.5M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $235.8M | $1.2B | $718.9M | -$17.7M | $89.8M | |
Depreciation & Amoritzation | $215M | $208.5M | $208M | $251.2M | $268.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $354.7M | $892.7M | $602.8M | $185M | $161M | |
Capital Expenditures | $263.4M | $429.1M | $485.1M | $403.7M | $278.9M | |
Cash Acquisitions | -$45.9M | -$29.8M | -$56.3M | -$6.4M | $800 | |
Cash From Investing | -$297.3M | -$432.5M | -$515.4M | -$394.2M | -$267.7M | |
Dividends Paid (Ex Special Dividend) | -$13.7M | -$200.7M | -$352M | -$4.9M | -$18.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $258.3M | $698.1M | $292.3M | $257.3M | $188.5M | |
Long-Term Debt Repaid | -$224.8M | -$775.7M | -$172.9M | -$101.5M | -$155M | |
Repurchase of Common Stock | -$3.3M | -- | -- | -- | -- | |
Other Financing Activities | -$15.2M | -- | $199K | -- | -- | |
Cash From Financing | $209.2M | -$283.4M | -$227.6M | $107.3M | -$9.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $266.6M | $176.8M | -$140.3M | -$101.9M | -$116.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $91.3M | $463.6M | $117.7M | -$218.7M | -$118M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $190.9M | $755.1M | $183.8M | $7.1M | $30.8M | |
Depreciation & Amoritzation | $113.8M | $102.8M | $103.2M | $127M | $130.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $214.5M | $537.2M | $171.9M | $95.4M | $67.9M | |
Capital Expenditures | $134.3M | $184.5M | $231.7M | $164.1M | $127.7M | |
Cash Acquisitions | -$9.3M | -$30M | -$42.1M | $556K | -- | |
Cash From Investing | -$148.3M | -$211.1M | -$268.9M | -$162.3M | -$123.5M | |
Dividends Paid (Ex Special Dividend) | -$11.4M | -$201M | -$355.5M | -- | -$18.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $245.8M | $575.3M | $176.6M | $64.4M | $23.6M | |
Long-Term Debt Repaid | -$177.4M | -$584M | -$4.8M | -$81.5M | -$99.7M | |
Repurchase of Common Stock | -$3.3M | -- | -- | -- | -- | |
Other Financing Activities | -$119.2K | -$105.8K | $93.2K | -- | -- | |
Cash From Financing | $268.8M | -$253.3M | -$179.6M | -$26.3M | -$104.6M | |
Beginning Cash (CF) | $858.7M | $1.7B | $2B | $1.2B | $946.4M | |
Foreign Exchange Rate Adjustment | $3.8M | $34.7M | $29.9M | $7.6M | -$26.9M | |
Additions / Reductions | $335M | $72.8M | -$276.5M | -$93.3M | -$160.2M | |
Ending Cash (CF) | $1.2B | $1.8B | $1.7B | $1.1B | $800.2M | |
Levered Free Cash Flow | $80.2M | $352.7M | -$59.7M | -$68.8M | -$59.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.